CART-EGFRvIII + Pembrolizumab in GBM
Clinical trial NCT03726515 · COMPLETED
Trial details
- NCT number
- NCT03726515
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2021-02-27
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.